The purpose of this study was to evaluate the influence of endothelial nitric oxide synthase (eNOS) deficiency on fetal growth, perinatal survival, and limb development in a mouse model with a targeted mutagenesis of the Nos3 gene. Wild-type (Nos3 ؉/؉ ) and eNOS-deficient fetuses (Nos3 Ϫ/Ϫ ) were evaluated on Gestational Day (E)15 and E17, and newborn pups were observed on Day 1 of life (D1). The average term duration of pregnancy was 19 days. For the evaluation of postnatal development, a breeding scheme consisting of Nos3 ؉/Ϫ ؋ Nos3 ؉/Ϫ and Nos3
INTRODUCTION
The free radical nitric oxide (NO) is synthesized during the conversion of L-arginine to L-citrulline by the enzyme nitric oxide synthase (NOS). Three isoforms of NOS have been identified: endothelial (e)NOS, inducible (i)NOS, and neuronal (n)NOS [1] [2] [3] . Nitric oxide is known to mediate a wide variety of physiological functions, including neurotransmission and immune cell cytotoxicity [3] . Nitric oxide has also been shown to regulate vascular tone by diffusing from endothelial cells into adjacent vascular smooth 1 This work was supported in part by the Erwin-Schroedinger-Auslandsstipendium J1839-MED with funding by the Fonds Zur Foerderung der Wissenschaftlichen Forschung (to L.H.). muscle cells, where it causes relaxation via a guanylate cyclase pathway [2] .
Abundant evidence points to a role for NO as an important mediator of uteroplacental blood flow and uterine quiescence during pregnancy [4] [5] [6] [7] [8] . In rodent models, various studies have shown that inhibition of NO synthesis during pregnancy causes decreased placental and fetal perfusion and subsequently results in fetal growth restriction [9] [10] [11] [12] . However, another line of evidence suggests that fetal growth restriction caused by NOS inhibitors such as N G -nitro-L-arginine methyl ester (L-NAME) is not due to the absence of NO but due to a modulation of the amino acid delivery to the fetus and subsequent aberrant protein synthesis [13] . Furthermore, it has been suggested that L-NAME causes fetal growth restriction by a reduction in cellular proliferation due to the induction of apoptosis [14] . Overall, inhibition of NOS has been shown to be closely associated with fetal growth restriction. The pathophysiological mechanisms, however, remain controversial.
Inhibition of NOS has been closely linked to limb malformations in rodent models [11, 15] . In this regard, L-NAME has been shown to disrupt the fetal limb in a sequential process. Initially, NO is depleted, causing hemorrhage and edema in the limb. Subsequently, iNOS is induced, resulting in cytotoxic tissue concentrations of NO that induce apoptosis and/or necrosis in the limb [16] . Thus, L-NAME exposure has been proposed as a model of vascular disruptive limb malformations. In our laboratory, mice deficient for eNOS were previously shown to have an increased frequency of limb defects [17] . We suggested that these limb lesions resulted from reduced blood flow to developing limbs. Others have suggested a mechanism of impaired bone formation and remodelling among eNOS-deficient offspring [18] .
The aim of this study was to characterize the effect of eNOS deficiency on late fetal and early postnatal development. We also sought to elucidate further the timing and frequency of previously reported limb deficiencies in this mouse model.
MATERIALS AND METHODS

Animal Husbandry
Approval for animal studies was obtained through the Internal Review Board at Baylor College of Medicine, Houston, TX. Animal husbandry practices followed guidelines established by the Animal Care Committee of Baylor College of Medicine. Animals were subjected to daily 12-h alternating periods of light and dark within a humidityand temperature-controlled environment. Food and water were provided ad libitum. The F 1 generation homozygous Nos3-deficient mice (Nos3 Ϫ/Ϫ ) were generated as previously described [17] . In order to compare mice homozygous for either the wild type or mutant allele without the need to perform repeated genotyping, Nos3
Ϫ/Ϫ and Nos3 ϩ/ϩ females were timed mated with Nos3 Ϫ/Ϫ and Nos3 ϩ/ϩ males, respectively. The duration of the mating period was 2 h per day (0800 h to 1000 h). Vaginal ostia were gently checked for a semen plug using an appropriately sized blunt glass rod. Identification of a vaginal semen plug defined embryonic Day 0 (E0).
Pregnant mice and fetuses of time-mated wildtype (Nos3 ϩ/ϩ ϫ Nos3 ϩ/ϩ ) and Nos3-deficient (Nos3 Ϫ/Ϫ ϫ Nos3 Ϫ/Ϫ ) breeding pairs were anesthetized (by inhalation with metophane) and killed on E15 and on E17 between 1000 h and 1200 h. A cardiac puncture was performed, the obtained maternal blood was centrifuged (5000 rpm ϫ 5 min), and the serum was stored at Ϫ20ЊC. Fetuses and placentae were weighed together and then separately. Crownrump lengths (CRL) were recorded using a dissecting microscope (Stereomicroscope SV11; Carl Zeiss, Inc., Thornwood, NY) at a magnification of 6.5ϫ. Measurements were obtained using an eyepiece monocle in which 10 units on the monocle scale were equivalent to 18.06 mm. Resorptions and fetal demises were also noted. Resorptions of pregnancies were identified as red discolorations of the uterine wall seen using dissecting microscopy. Fetal demises were defined as animals that could be recognized grossly although partially autolyzed at the time killed. A histologic evaluation was performed on limbs determined grossly and using dissecting microscopy to be abnormal. For assessment of newborn pups, cages were surveyed daily from E17 through delivery. On day of life (D)1, pups were weighed in aggregate, and the numbers of pups alive and dead were recorded. Limbs were grossly inspected from D1 through D7, and histology was obtained when abnormalities were identified. All tissues assessed histologically were first fixed in 10% buffered formalin and hematoxylin and eosin staining was performed.
In a separate series of experiments, two breeding schemes (Nos3 ϩ/Ϫ ϫ Nos3 ϩ/Ϫ and Nos3 Ϫ/Ϫ ϫ Nos3 Ϫ/Ϫ ) were established in order to compare reproductive outcomes of pups including their aggregate litter weights. There were five cages used for each scheme. Each cage contained one sexually mature male and two sexually mature females. The establishment of breeding cages was limited by availability of mature mice of the appropriate genotype. For this reason, the number of litters achieved from each group was normalized to the number of breeding females observed each week. Mice were allowed to breed spontaneously, and cages were surveyed daily for 10 mo. Aggregate litter weights were obtained for each day from D1 to D21. The aggregate litter weight was divided by the number of viable pups on each day, and average pup weights were obtained.
Genotyping
Nos3-deficient mice (Nos3
Ϫ/Ϫ ) generated by targeted mutagenesis of exon 1 of Nos3 were genotyped as described previously [17] . Briefly, mouse genomic DNA for genotyping was obtained from proteinase K-digested tails using phenol-chloroform extraction. Genomic DNA was digested using the restriction enzyme EcoRI (Boehringer Mannheim, Indianapolis, IN). Equal amounts of DNA (15 g) were electrophoresed on a 1% agarose gel, denatured in 0.4 M NaOH for 45 min, and transferred overnight onto nucleic acid transfer membranes (Amersham, Piscataway, NJ) using 10ϫ SSC (0.75 M sodium chloride and 0.075 M sodium citrate, pH 7.0; Fisher Scientific, Fairlawn, NJ). The membranes were prehybridized at 64ЊC in a hybridization buffer containing 0.5 M sodium phosphate (Fisher Scientific), 1 mM EDTA (J.T. Baker, Inc., Phillipsburg, NJ), 7% SDS (Boehringer Mannheim), 10% polyethylene glycol 8000 (Fisher), 1 g/ml BSA (fraction V; Sigma, St. Louis, MO), and 100 g/ml denatured salmon sperm DNA (Sigma). After 6 h, Southern blots of genomic DNA were hybridized at high stringency with a 510-base pair (bp) probe of mouse Nos3 cDNA that had been labeled using random primers [␣-32 P]dCTP. After hybridization for 18 h at 64ЊC, membranes were washed sequentially at 64ЊC for 20 min with 5ϫ SSC, 2ϫ SSC, 1ϫ SSC, 0.5ϫ SSC, and 0.1% SDS (Sigma) with two cycles for each stringency. The membranes were air-dried, wrapped in Saran wrap, and exposed to an autoradiography film (Amersham) for 48 h. Genotypes were determined by visual inspection of autorads. In wild-type mice the EcoRI restriction fragment length polymorphism has a size of 9.8 kilobases (kb). In Nos3 Ϫ/Ϫ mice the EcoRI restriction fragment is 4.8 kb due to the deletion event. This difference was used to distinguish between the mutant and the wild-type allele.
Bone-Staining Protocol
The method used to stain bone and cartilage was performed as described [19] . The Nos3 Ϫ/Ϫ newborns (n ϭ 14) and Nos3 ϩ/ϩ (n ϭ 7) newborns were eviscerated and placed in water overnight. Skeletons were immersed in a 65ЊC water bath for 1 min, skinned, and fixed in ethanol for 3 days. Alcian blue 8GX (15 mg; Sigma) was added to 80 ml of 95% ethanol and 20 ml of glacial acid. Cartilage was stained for 8-12 h, rinsed in 100% ethanol overnight, and cleared in 2% KOH for 6 h. Alizarin red (50 mg; Sigma) was added to 1 L of 2% KOH, and skeletons were immersed for 3 h to counterstain bone. Skeletons were cleared in 2% KOH and stored in 100% glycerol. Bone lengths were recorded using a dissecting microscope (Stereomicroscope SV11; Carl Zeiss) and a magnification of 50ϫ. Measurements were obtained using an eyepiece monocle in which 10 units on the monocle scale were equivalent to 2 mm. Bone lengths were corrected for the observation of reduced birth weight among Nos3 Ϫ/Ϫ mice compared to Nos3 ϩ/ϩ mice. Linear measurements were divided by pup weights obtained just prior to being killed on D1.
Serum was first ultrafiltered to eliminate proteins using a 10 000 molecular weight filter (Centricon Centrifugal Filter Devices, YM 10; Millipore Corp., Bedford, MA). For the measurement of endogenous nitrite and total nitrite (after conversion of nitrate to nitrite by NADH and nitrate reductase), a commercially available ELISA was used (nitric oxide assay [NO 2 Ϫ /NO 3 Ϫ ]; R&D Systems, Minneapolis, MN). All serum analyses were performed at the same time and in the same batch according to manufacturer's instructions. Standard curves for the obtained values of endogenous nitrite (mol/L) and total nitrite (mol/L) were constructed, and total nitrate values (mol/L) were calculated with the formula: total nitrite concentration (mol/L) Ϫ endogenous nitrite (mol/L).
Statistics
The statistical software Sigma Stat version 2.0 (Jandel Scientific, San Rafael, CA) was used for statistical analysis. All values were checked for normal distribution by the Kolmogorov-Smirnov normality test. In the case of normally distributed values (normality test, P Ͼ 0.05), means are 
FIG. 1. Box plots of weights of Nos3
ϩ/ϩ and Nos3 Ϫ/Ϫ fetuses/pups on E15, E17 and D1. Horizontal lines in the boxes represent the first, second (the median), and third quartiles; whiskers (vertical lines) extend from the box to a distance of 1.5 interquartile ranges; ▫ represents the mean, and x represents values outside a distance of 1.5 interquartile ranges from the box. The number of pups represented in each group is shown in Table 1 .
given; in case of skewed, i.e., not normally distributed, values (normality test, P Ͻ 0.05), medians are given to describe our data. Where appropriate Student's t-test (normally distributed data), Mann-Whitney Rank Sum Test (non-normal data), Fisher Exact Test, and Kruskal-Wallis One Way-ANOVA on Ranks with Dunn's test for multiple comparisons were performed. Significance was assumed at P Ͻ 0.05. Measurements of the bones of the forelimb and hindlimbs were pooled (right and left). Linear measurements were compared using Student's t-test, and P-values were adjusted for multiple comparisons using the method of Bonferroni [20] . Figures 1, 2 , and 3, were generated using the graphing software Origin, 4.1 (Microcal, Northampton, MA).
RESULTS
Perinatal Growth
The number of litters, the respective number of fetuses/ pups, and the median number of fetuses or pups/litter investigated for E15, E17, and newborns (D1) are shown in Table 1 . There were no differences in the total number of litters, fetuses, or newborns assessed. Figure 1 shows a box plot of fetal/pup weights of Nos3 ϩ/ϩ and Nos3 Ϫ/Ϫ fetuses on E15, E17, and D1, respectively. No significant difference in mean fetal weight was seen between Nos3 ϩ/ϩ and Nos3
fetuses on E15 (0.34 g and 0.32 g, respectively); however, Nos3 Ϫ/Ϫ fetuses showed significantly lower mean weights on E17 (0.83 g vs. 0.74 g, respectively; P Ͻ 0.001). On D1, the difference between median pup weights of Nos3
and Nos3 Ϫ/Ϫ pups was more apparent (1.45 g vs. 1.3 g; P ϭ 0.02). On E15, no difference was seen in mean CRL between Nos3 ϩ/ϩ and Nos3 Ϫ/Ϫ fetuses (14.7 mm vs. 14.5 mm; P ϭ 0.3), whereas on E17, Nos3 ϩ/ϩ fetuses had a significantly greater mean CRL than Nos3 Ϫ/Ϫ fetuses (21.4 mm vs. 20.6 mm; P ϭ 0.02). Mean placental weights were seen to be reduced significantly in Nos3 Ϫ/Ϫ pregnancies on E17 (0.10 g vs. 0.11 g; P ϭ 0.03), whereas no difference was seen on E15. Careful evaluation of placental histology on E15 (n ϭ 7) and E17 (n ϭ 9) revealed no immediate differences that could be attributed to genotype variation.
In the separate series evaluating postnatal growth, the total number of litters in each group (Nos3 ϩ/Ϫ ϫ Nos3 Ϫ/Ϫ E17 fetus. Macroscopic hemorrhage of entire limb was observed in addition to shortening of the third and fourth digits. Microscopically, the metatarsals appeared short (arrow), and several distal phalanges were absent. Of note, the cartilage analgen are surrounded by lakes of blood, the epidermis is intact (arrowhead), and blood vessels within the limb appear constricted. B) Transversal section of a hematoxylin and eosin-stained left hindpaw from a Nos3 ϩ/ϩ E17 fetus. No macroscopic or microscopic abnormalties were noted. Ϫ/Ϫ females. The average number of pups per litter was the same for each group (n ϭ 6). The average weight of pups plotted as a function of postnatal day of life (D1 to D21) is shown in Fig. 2 . The same general pattern of weight gain was observed for offspring derived from either mating scheme. However, similar to that observed in the short-term study as described above, on D1 the average pup weight was significantly lower for Nos3 Ϫ/Ϫ pups compared to Nos3 ϩ/Ϫ offspring (1.4 g vs. 1.5 g; P Ͻ 0.001). This difference was accentuated throughout the remaining postnatal observation period, and we observed no catch-up growth of Nos3 Ϫ/Ϫ pups. [n ϭ 5]) are shown in Figure 3 . No significant differences were found between any groups.
Length of Pregnancy and Intrauterine and Neonatal Survival
The average length of pregnancy did not differ between Nos3 ϩ/ϩ (n ϭ 6) and Nos3 Ϫ/Ϫ (n ϭ 9) females (19 days
FIG. 5. Transversal section of a hematoxylin and eosin-stained right forelimb from a Nos3
Ϫ/Ϫ pup on D1. Mascroscopically, the forearm appeared to be missing. Microscopically, the humerus was dramatically shortened (short arrow). Only fragments of the proximal radius and ulna could be seen (long arrow). Once again the epidermis was intact over the distal developing limb (arrowhead). each group). Intrauterine survival on E15 and E17 was independent of Nos3 genotype. On E15, no fetal deaths were detected in either group. On E17, 0 of 29 and 2 of 38 intrauterine deaths were seen in Nos3 ϩ/ϩ and Nos3 Ϫ/Ϫ fetuses, respectively (P ϭ 0.5). No differences were seen in number of absorptions on either day. In pregnancies of Nos3 ϩ/ϩ females, the median number of pups alive did not differ on E15, E17, and D1 (6.5, 7.5, and 5.5, respectively; P ϭ 0.6). Of note, in pregnancies of Nos3 Ϫ/Ϫ females, the median number of pups alive on D1 was significantly lower than that observed on either E15 or E17 (6.0 vs. 8.0 vs. 8.0; P ϭ 0.004).
Limb Deficiencies and Bone Measurements in Fetuses and Newborn Pups
On E15 and E17, 0 of 32 and 1 of 38 of Nos3 Ϫ/Ϫ fetuses had acute hemorrhage in the limbs. The macroscopic findings we previously reported [17] were similar to that observed in the affected E17 fetus. The affected right hindlimb was grossly hemorrhagic with short digits. The microscopic findings were consistent with a vascular etiology. Constricted arterioles were observed and hemorrhage was seen in the area of the cartilagenous anlagen ( Figure 4A ). To allow for comparison, Figure 4B shows a normally developed right hindpaw on E17. At term, 3 of 49 Nos3 Ϫ/Ϫ pups showed limb deficiencies. One of these pups had lesions of a fore-and hindlimb. The forelimb demonstrated total absence of the right distal limb beyond the humerus. In addition the right hindpaw showed focal hemorrhagic necrosis of phalanx 2, 3, and 4. The microscopic appearance of the forelimb lesion showed an intact epidermis with hypoplasia of the humerus and only boney fragments representing the ulna and radius (Fig. 5) . In the case of another pup the entire left forepaw was pale white, indicative of an ischemic lesion. The third pup showed macroscopic evidence of acute hemorrhage involving phalanx 2 and 4 of the right hindpaw. There were no focal acute hemorrhages (hemorrhagic blebs) or gross limb abnormalities observed among Nos3 ϩ/ϩ fetuses/pups. Data for forepaw and hindpaw measurements are shown in Tables 2 and 3 , . The lengths of forepaw bones were not significantly different between Nos3 ϩ/ϩ and Nos3 Ϫ/Ϫ pups. When digits of the hindpaw were evaluated (bones for each digit were summed), significant differences were seen in peripheral digits (1 and 5) . The Nos3 Ϫ/Ϫ digits were smaller than those of Nos3 ϩ/ϩ mice. A review of Table 3 demonstrates that although individual bone measurements or digits do not reach statistical significance, in nearly each case mean or median values derived from Nos3 Ϫ/Ϫ mice are smaller than those derived from Nos3 ϩ/ϩ mice. The only exclusion to this observation appears to be the second digit metatarsal and first phalanx.
DISCUSSION
Our data demonstrate a characteristic phenotype among eNOS-deficient mice including fetal growth restriction and developmental abnormalities of the limbs. Interestingly, the onset of these features can be traced to the late prenatal period, and they persist well into postnatal life.
The roles for NO in various physiological and pathophysiological processes in pregnancy are abundant [4] . In humans, studies have shown that NO mediates uteroplacental blood flow and uterine quiescence [4, 21] . In pathological conditions such as fetal growth restriction and preeclampsia, overexpression of eNOS has been widely regarded as an adaptive response to compensate for decreased P-value after Bonferroni correction. # Digits 1-5 refer to digits labeled medial to lateral, respectively. Phalanx 1-3 refer to proximal to distal phalanges, respectively. Values in bold refer to summed bone lengths for a single digit. Summing was only performed when all bones could be measured for the respective digit.
placental blood flow [6, 7] . A relative deficiency of placental NO synthesis has been speculated to be a predisposing factor for acquiring conditions such as fetal growth restriction or pre-eclampsia [22] [23] [24] [25] .
Mice lacking functional eNOS have been previously generated [17, 26, 27] and their reproductive phenotypes have been described [26, [28] [29] [30] [31] [32] . These mice demonstrate elevated blood pressure in the nonpregnant state [26] . Blood pressure is also elevated throughout pregnancy and appears to increase as pregnancy progresses [29] . In addition, decreased postnatal survival was confirmed independently after studies of offspring derived from heterozygous matings demonstrated a skewing away from the expected Mendelian ratio of 1:2:1 (wild type:heterozygous deficient: homozygous mutant, respectively) [17, 26] . Furthermore, limb abnormalities were observed among 8% of eNOS-deficient offspring [17] .
In this study we focused our attention on the peripartum period. We showed that reduced growth occurs prior to delivery among eNOS-deficient conceptuses. All parameters used to assess fetal growth point to a period between E15 and E17 as a critical time of embryonic development. Pup weight, placental weight, and CRL were significantly reduced among mutant mice on E17. With regard to postnatal growth, our data show that absence of eNOS results in continued growth delay through D21.
Possible biologic etiologies of these aberrant growth curves include reduced uteroplacental blood flow, altered fetal blood flow patterns, reduced growth potential, and postnatal behavioral changes that affect either maternal rearing or neonatal feeding patterns. The known biology of NO derived from eNOS lends credence to alterations in vascular tone as a primary cause. To improve upon this hypothesis, we set out to measure serum concentrations of NO metabolites (nitrite and nitrate) within the maternal circulation. We hoped to correlate these to the observation of reduced fetal growth. We observed no measurable differences in these metabolites when serum samples were obtained from pregnant mice on E15 or E17. Nitric oxide produced by eNOS is known to act locally. Its contribution to the total pool of NO metabolites in the circulation is thought to be small. We have previously proven that our mice show complete eNOS deficiency [17] . Although we cannot rule out compensatory overproduction of NO by other NOS isoforms, it is more likely that NO metabolites derived from food sources account for a large percentage of the circulating NO metabolites. Thus, our observations leave open the possibility that local eNOS deficiency caused reduced uteroplacental perfusion. Altered circulating systemic NO levels are apparently no link between eNOS deficiency and reduced fetal growth.
Nitric oxide has also been shown to be involved in the process of bone development [18] . High NO levels were found to inhibit osteoclast-mediated bone resorption in vivo and in vitro [33] . Decreased NO production has been shown to potentiate osteoclast bone resorption in vitro and was associated with in vivo bone loss in rats [33] . With respect to human pathological conditions, NO has been suggested to act as mediator of bone disease such as rheumatoid arthritis, tumor-associated osteolysis, and postmenopausal osteoporosis [18] . Possible treatment with NO donors has been proposed [34, 35] . One aim of this study was to characterize the onset of limb abnormalities among eNOS-deficient offspring. Gross limb abnormalities were first seen on E17, and none were identified on E15. Abnormalities of the limbs were more severe on D1. Our data suggest an acute and chronic effect of eNOS-derived NO deficiency on bone development. Identification of an intact epidermis overlying hypoplastic long bones and shortened digits might indicate a chronic effect, whereas the hemorrhagic events with vasoconstriction suggest an acute process. The data we presented do not address the inciting event for the acute hemorrrhage and vascular smooth muscle constriction. Furthermore, speculation still exists as to whether the etiology of the chronic effects results from direct effects on bone cells or is due to chronic vascular insufficiency in more distal branching vessels. Similar to the observations of altered fetal growth, the period from E15 to E17 appears to be critical with respect to NO derived from eNOS and limb formation.
Our study of bone lengths was undertaken as a result of prior observations [17] . We noted that after staining bone and cartilage of mice with gross abnormalities of a single limb, the contralateral normal-appearing limb manifested features of boney hypoplasia. We postulated that bone growth was being stunted by chronically reduced flow to developing limbs as compared to an acute event seen in only 6% of mice with obvious defects. Our data give merit to this hypothesis. Due to the small bones in newborn mice, the bone-staining and measurement procedure we described did not allow all phalanges in all pups to be measured accurately. This fact accounts for the different number of bones studied for each digit. Despite the absence of gross limb abnormalities, nearly every bone of eNOS-deficient D1 mice was smaller in the hind paws (except for the second metatarsal). We also found it interesting that bones of the central hindpaw approached those of wild-type mice compared to those around the periphery of the hindpaw. Once again these findings support a role for altered blood flow in the distal and periphery of developing hind paws.
An observation of greater branching of blood vessels to these areas resulting in smaller caliber vessels may support this view [28] . We are unclear as to why the bones of the forepaw did not show a similar pattern of reduced linear growth. This could be due to the small number of mice evaluted. Of note, the same method of measuring resulted in significant albeit small reductions in growth of the hindpaw versus the forepaw. It is not unusual that teratogens known to alter blood flow patterns during fetal development yield variation with respect to either sideness or demonstrate a preference for hindpaw or forepaw effects [11, 36] . Our data support the observations by others and suggest that eNOS in mouse development may play a preferential role with regard to hindpaw development. It should be pointed out that the data presented in Tables 2 and 3 are for pups with grossly normal-appearing limbs. Therefore, it was expected that when differences in bone length of the hindpaw occurred, these were quantitatively small. This does not minimize the importance of this observation. Instead, this underlines the fact that eNOS deficiency can impact limb growth along a full spectrum that includes total deficiency (Fig. 5 ) and the subtleties pointed to in Table 3 . We observed a low frequency of gross limb abnormalities. This might lead to speculation that eNOS does not play a major role in limb development. However, the finding of a more subtle phenotype, reduced bone length, suggests that eNOS may be more important than the frequency of gross abnormalities would imply. The same can be stated for the role of eNOS and the impact on overall growth. A 10% reduction in growth as a result of eNOS deficiency seems small. However, the importance of identifying a single factor among the many biologic pathways and compensatory mechanisms that exist to influence fetal growth should not be underrated. Overall, we believe that the small differences we observed do have biological relevance. The phenotypic changes were in the direction expected for eNOS deficiency. Furthermore, despite available compensatory mechanisms (pathways promoting vasodilation), measurable statistical differences were ascertained.
Our data show more fetal demises and absorptions in pregnancies in the Nos3 Ϫ/Ϫ group, but no statistical significance was reached. However, we found a significantly reduced number of Nos3 Ϫ/Ϫ newborns compared to fetuses on either E15 or E17 that was not found in Nos3 ϩ/ϩ controls. We believe this observation is not serendipitous. This time period corresponds to the identification of growth deficiency and the identification of limb abnormalities. It is quite likely that the carcasses of either late fetal deaths, early neonatal deaths, severely deformed pups, or pups with abnormal feeding behavior were cannibalized shortly after birth.
In summary, mice deficient for eNOS show characteristically abnormal prenatal and postnatal development. These features date to a period between 15 and 17 days of embryonic life and persist to at least Day 21 of postnatal life. Furthering our understanding of the requirement of eNOS in late development may provide insights into limb growth and development and the mechanisms underlying fetal growth restriction observed during human pregnancies.
